Sponsor:
UCLA
Code:
NCT06252675
Conditions
Mantle Cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Obinutuzumab
Glofitamab
Pirtobrutinib
Tumor Imaging
Biospecimen Collection
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-30. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2025-10-22.